Liver metastases occur in 46-93% of patients with neuroendocrine neoplasms (NENs). Presence and extension of liver metastases are considered important prognostic factors, as they may significantly impair the patient's quality of life, because of either tumor bulk or hormonal hypersecretion. Therapies for NEN liver metastases include surgical resection, liver transplantation, chemotherapy and biotherapy. Surgery is the gold standard for curative therapy, but in most of NEN patients with liver metastases, when surgery can not be applied, minimally invasive therapeutic approaches are adopted. They include trans-arterial embolization (TAE), trans-arterial chemoembolization (TACE), radiofrequency thermal ablation and new emerging techniques.TAE is based on selective infusion of particles in the branch of the hepatic artery supplying the tumor lesions. The goal of TAE is to occlude tumor blood vessels resulting in ischemia and necrosis. Many reports have shown that TAE can reduce tumor size and hormone output, resulting in palliation of symptoms without the use of cytotoxic drugs, resulting in better tolerability. This review will focus on TAE performance and safety in NEN patients with liver metastases.

Hepatic arterial embolization in patients with neuroendocrine tumors / DEL PRETE, Michela; Fiore, F; Modica, Roberta; Marotta, Vincenzo; Marciello, Francesca; Ramundo, Valeria; DI SARNO, Antonella; Carratù, A; di Roseto Cde, L; Tafuto, S; Tatangelo, F; Baldelli, R; Colao, Annamaria; Faggiano, Antongiulio; Multidisciplinary Group for NeuroEndocrine Tumors of, N. a. p. l. e. s.. - In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. - ISSN 1756-9966. - 33:1(2014). [10.1186/1756-9966-33-43.]

Hepatic arterial embolization in patients with neuroendocrine tumors.

DEL PRETE, MICHELA;Modica, Roberta;MAROTTA, VINCENZO;MARCIELLO, FRANCESCA;RAMUNDO, VALERIA;DI SARNO, ANTONELLA;COLAO, ANNAMARIA;FAGGIANO, ANTONGIULIO;
2014

Abstract

Liver metastases occur in 46-93% of patients with neuroendocrine neoplasms (NENs). Presence and extension of liver metastases are considered important prognostic factors, as they may significantly impair the patient's quality of life, because of either tumor bulk or hormonal hypersecretion. Therapies for NEN liver metastases include surgical resection, liver transplantation, chemotherapy and biotherapy. Surgery is the gold standard for curative therapy, but in most of NEN patients with liver metastases, when surgery can not be applied, minimally invasive therapeutic approaches are adopted. They include trans-arterial embolization (TAE), trans-arterial chemoembolization (TACE), radiofrequency thermal ablation and new emerging techniques.TAE is based on selective infusion of particles in the branch of the hepatic artery supplying the tumor lesions. The goal of TAE is to occlude tumor blood vessels resulting in ischemia and necrosis. Many reports have shown that TAE can reduce tumor size and hormone output, resulting in palliation of symptoms without the use of cytotoxic drugs, resulting in better tolerability. This review will focus on TAE performance and safety in NEN patients with liver metastases.
2014
Hepatic arterial embolization in patients with neuroendocrine tumors / DEL PRETE, Michela; Fiore, F; Modica, Roberta; Marotta, Vincenzo; Marciello, Francesca; Ramundo, Valeria; DI SARNO, Antonella; Carratù, A; di Roseto Cde, L; Tafuto, S; Tatangelo, F; Baldelli, R; Colao, Annamaria; Faggiano, Antongiulio; Multidisciplinary Group for NeuroEndocrine Tumors of, N. a. p. l. e. s.. - In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. - ISSN 1756-9966. - 33:1(2014). [10.1186/1756-9966-33-43.]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/600177
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 43
  • ???jsp.display-item.citation.isi??? ND
social impact